Mitral valve repair for infective endocarditis

Objective This study investigated the feasibility of mitral valve (MV) repair in patients with active or healed infective endocarditis (IE) with mitral regurgitation and evaluated effects on left ventricular (LV) function and structure. Methods Subjects comprised 19 patients who underwent MV operati...

Full description

Saved in:
Bibliographic Details
Published inGeneral thoracic and cardiovascular surgery Vol. 56; no. 6; pp. 277 - 280
Main Authors Omoto, Tadashi, Ohno, Masahiro, Fukuzumi, Masaomi, Ohi, Masaya, Okayama, Takahisa, Ishikawa, Noboru, Kasegawa, Hitoshi, Tedoriya, Takeo
Format Journal Article
LanguageEnglish
Published Japan Springer Japan 01.06.2008
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1863-6705
1863-6713
DOI10.1007/s11748-007-0209-4

Cover

More Information
Summary:Objective This study investigated the feasibility of mitral valve (MV) repair in patients with active or healed infective endocarditis (IE) with mitral regurgitation and evaluated effects on left ventricular (LV) function and structure. Methods Subjects comprised 19 patients who underwent MV operations for IE between December 2004 and September 2007. MV repair was performed for acute IE in 10 of 15 patients (67%) and for healed IE in 4 of 4 patients (100%). Results No early or late postoperative deaths were encountered. One patient underwent redo MV repair owing to severe mitral regurgitation 1 month postoperatively. Postoperative echocardiography after MV repair demonstrated less than trivial (acute IE in seven, healed IE in three) or mild (acute IE in three, healed IE in one) mitral regurgitation. In patients with MV replacement, the postoperative left atrial dimension (LAD) was decreased (51.5 ± 39.2 vs. 39.2 ± 1.9 mm, P = 0.007); however LV end-diastolic dimension (LVDD) and LV end-systolic dimension were unchanged. In patients with MV repair, LVDD (57.5 ± 6.5 vs. 46.0 ± 5.6 mm, P < 0.001), LV end-systolic dimension (36.1 ± 5.2 vs. 32.4 ± 6.2 mm, P = 0.04), LAD (43.1 ± 8.1 vs. 33.6 ± 7.7 mm, P = 0.003) were reduced. Postoperative ejection fraction (55.3 ± 13.5% vs. 41.8% ± 10.0%, P = 0.03) and fraction shortening (30.1% ± 9.2% vs. 20.7% ± 5.5%, P = 0.03) were better in patients with MV repair than those with MV replacement. Conclusions MV repair is feasible in patients with both active and healed IE. MV repair preserves better LV function and structure postoperatively.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:1863-6705
1863-6713
DOI:10.1007/s11748-007-0209-4